Andrew Craig Miller - 09 Feb 2024 Form 4 Insider Report for Karuna Therapeutics, Inc.

Role
President of R&D
Signature
/s/ Mia Kelley, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
09 Feb 2024
Net transactions value
-$320,629
Form type
4
Filing time
12 Feb 2024, 17:11:39 UTC
Previous filing
20 Apr 2023
Next filing
15 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Tax liability $320,629 -1,011 -4.1% $317.14 23,389 09 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the partial vesting of restricted stock units previously granted to the Reporting Person on February 9, 2023.

Remarks:

Exhibit 24 - Power of Attorney